|
Volumn 19, Issue 22, 2011, Pages 6842-6852
|
C4-Alkylthiols with activity against Moraxella catarrhalis and Mycobacterium tuberculosis
|
Author keywords
Lactams; Antimicrobial resistance; Moraxella catarrhalis; Mycobacterium tuberculosis
|
Indexed keywords
(2 ETHYL 2 MERCAPTOBUTYLIDENEAMINO)ACETIC ACID ETHYL ESTER;
(2 METHYL 2 METHYLDISULFANYLPROPYLIDENEAAMINO)ACETIC ACID ETHYL ESTHER;
2 (4 MERCAPTOPHENOXY) 4 OXO AZETIDINE 1 SULFONIC ACID TETRA N BUTYLAMMONIUM;
2 (4 MERCAPTOPHENYLAMINO) 4 OXO AZETIDINE 1 SULFONIC ACID TETRA N BUTYLAMMONIUM;
2 (4 MERCAPTOPHENYLSULFANYL) 4 OXO AZETIDINE 1 SULFONIC ACID TETRA N BUTYLAMMONIUM;
2 ACETYLSULFANYL 4 OXO AZETIDINE 1 SULFONIC ACID TETRA N BUTYLAMMONIUM;
2 OXO 4 (THIOPHEN 2 YLSULFANYL)AZETIDINE 1 SULFONIC ACID TETRA N BUTYLAMMONIUM;
2 OXO 4 PHENYLSULFANYLAZETIDINE 1 SULFONIC ACID TETRA N BUTYLAMMONIUM;
2ETHYL 2 MERCAPTOBUTAN 1 OL;
4 (2ETHYL 2 MERCAPTOBUTOXY)AZETIDIN 2 ONE;
4 (3 HYROXYPROPYLSULFANYL)AZETIDIN 2 ONE;
4 (3 MERCAPTOPROPOXY)AZETIDIN 2 ONE;
4 (4 MERCAPTOPHENOXY)AZETIDIN 2 ONE;
4 (4 MERCAPTOPHENYLAMINO)AZETIDIN 2 ONE;
4 (4 MERCAPTOPHENYLSULFANYL)AZETIDIN 2 ONE;
4 (THIOPHEN 2 YLSULFANYL)AZETIDIN 2 ONE;
4 ACETHYLTHIO 2 AZETIDINONE;
4 PHENYLSULFANYLAZETIDIN 2 ONE;
[2 (1 ETHYL 1 MERCAPTOPROPYL) 3 METHOXY 4 OXO AZETIDIN 1 YL]ACETIC ACID ETHYL ESTER;
[2 [1 (ETHOXYCARBONYLMETHYLIMINOMETHYL) 1 ETHYLPROPYLDISULFANYL] 2 ETHYLBUTYLIDENEAMINO]ACETIC ACID ETHYL ESTER;
[2 [1 ETHYL 1 (1 ETHYL 1 FORMYLPROPYLDISULFANYL)PROPYL] 3 METHOXY 4 OXO AZETIDIN 1 YL]ACETIC ACID ETHYL ESTER;
[2 [1 ETHYL 1 (1 ETHYL 1 FORMYLPROPYLDISULFANYL)PROPYL] 3 METHOXY 4 OXO AZETIDIN 1 YL]ACETIC ACID METHYL ESTER;
[2 ETHYL 2 (1 ETHYL 1 FORMYLPROPYLDISULFANYL)BUTYLIDENEAMINO]ACETIC ACID ETHYL ESTER;
[2 ETHYL 2 (1 ETHYL 1 FORMYLPROPYLDISULFANYL)BUTYLIDENEAMINO]ACETIC ACID METHYL ESTER;
[3 METHOXY 2 (1 METHYL 1 METHYLDISULFANYL ETHYL) 4 OXOAZETIDIN 1 YL]ACETIC ACID ETHYL ESTHER;
ANTIINFECTIVE AGENT;
BETA LACTAM ANTIBIOTIC;
ETHYL 2 (1 ETHYL 1 FORMYLPROPYLDISULFANYL)BUTYRALDEHYDE;
UNCLASSIFIED DRUG;
ANTIBACTERIAL ACTIVITY;
ANTIBIOTIC RESISTANCE;
ANTIBIOTIC SENSITIVITY;
ANTIMICROBIAL ACTIVITY;
BACTERIAL STRAIN;
BACTERIUM ISOLATION;
CONFERENCE PAPER;
CONTROLLED STUDY;
DRUG DESIGN;
DRUG MECHANISM;
DRUG STRUCTURE;
DRUG SYNTHESIS;
MINIMUM INHIBITORY CONCENTRATION;
MORAXELLA CATARRHALIS;
MYCOBACTERIUM TUBERCULOSIS;
NONHUMAN;
PROTEIN EXPRESSION;
WILD TYPE;
ANTI-BACTERIAL AGENTS;
BETA-LACTAMASES;
BETA-LACTAMS;
MICROBIAL SENSITIVITY TESTS;
MODELS, MOLECULAR;
MORAXELLA (BRANHAMELLA) CATARRHALIS;
MYCOBACTERIUM TUBERCULOSIS;
SULFHYDRYL COMPOUNDS;
BACTERIA (MICROORGANISMS);
MORAXELLA CATARRHALIS;
MYCOBACTERIUM TUBERCULOSIS;
|
EID: 80054979839
PISSN: 09680896
EISSN: 14643391
Source Type: Journal
DOI: 10.1016/j.bmc.2011.09.030 Document Type: Conference Paper |
Times cited : (15)
|
References (34)
|